The sheer volume of research activity makes it impossible for R&D executives to stay informed. With BioWorld Science, we’ve applied the same BioWorld formula to cut through the clutter, and deliver the most impactful early stage and discovery updates every business day. Daily reports include an average of 25 late-breaking news articles delivered every business day with expanded technical details on:

• - The most promising compounds entering preclinical development
• - New mechanisms of action
• - Key studies from all major peer-reviewed journals
• - Conference highlights from more than 300 congresses
• - Chemical structure images
• - News categorized by all major diseases for quick reviews
• - Newly reported experimental models
• - And much more!

BioWorld Science also offers a unique value proposition: link seamlessly to corresponding records in our discovery and preclinical research database, Integrity, for a deeper dive and analysis.

The drug discovery landscape shifts too quickly to rely on decisions not based on the most up to date research available.  By signing up for the 15 day BioWorld Science trial, you’ll gain immediate access to the intelligence you need to make the important R&D decisions you face every day.



*To participate you must include a valid company email address. Clarivate Analytics reserves the right to disable any trial.